血清游离甲状腺素浓度在参考范围内的变化可预测非肥胖成人代谢综合征的发病率:一项队列研究
该研究基于德黑兰甲状腺研究的前瞻性人群队列,纳入2393名成人,随访10年,评估游离甲状腺素(fT4)和促甲状腺激素(TSH)在亚临床及正常范围内的变化对代谢综合征(MetS)及其组分发病率的影响。结果显示,fT4随时间升高与腹型肥胖和高甘油三酯血症风险降低相关,但与高血压风险升高相关;fT4降低与MetS风险增加相关,尤其在非肥胖成人中。TSH变化与MetS及其组分无关。
要点
- fT4升高与腹型肥胖风险降低(OR=0.49)和高甘油三酯血症风险降低(OR=0.57)相关。
- fT4升高与高血压风险升高相关(OR=1.35)。
- fT4降低与MetS风险增加相关,尤其在非肥胖成人中(β=0.49,p=0.007)。
核心结论
- 血清fT4降低与MetS风险增加相关,尤其在非肥胖成人中。
研究设计与样本
- 前瞻性人群队列研究,来自德黑兰甲状腺研究,纳入2393名成人,随访10年,每3年随访一次。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The association of changes in thyroid hormone values over time with the incidence of metabolic syndrome (MetS) has not yet been evaluated. For the first time, this study assessed the effect of thyroid hormone variations in the subclinical and euthyroid range on the incidence of MetS and its components over a 10-year follow-up in an adult population. METHODS: Data were analyzed from the prospective population-based Tehran Thyroid Study. Of 5786 randomly selected subjects aged ≥20 years, after excluding subjects with MetS (n = 1403), those with serum thyrotropin (TSH) >10 or <0.1 mIU/L (n = 104), those taking thyroid drugs (n = 85) or corticosteroids (n = 97), those with a body mass index (BMI) <18.5 kg/m2, those with a glomerular filtration rate <30, and those with a history of cancer (12), data for 2393 subjects were analyzed. Body weight, waist circumference, and blood pressure were measured, and serum concentrations of lipids and lipoproteins, fasting blood glucose, insulin, free thyroxine (fT4), and TSH were assayed at baseline and during three follow-up studies at three-year intervals. MetS was determined using definition of the Joint Interim Statement, adjusted for the Iranian population. RESULTS: An increase in fT4 values overtime was associated with lower odds of abdominal obesity (odds ratio [OR] = 0.49 [confidence interval (CI) 0.35-0.69]) and hypertriglyceridemia (OR = 0.57 [CI 0.41-0.78]), and with higher odds of hypertension (OR = 1.35 [CI 1.05-1.74]), adjusted for age, sex, smoking, BMI, and Homeostasis Model Assessment Index for Insulin Resistance. fT4 was associated with lower odds of MetS in the crude model, and after adjustment for age, sex, and smoking (OR = 0.59 [CI 0.39-0.9]). This association lost its significance after further adjusting for BMI. In a subgroup analysis of obese (i.e. BMI ≥30 kg/m2) and non-obese (i.e., BMI <30 kg/m2) subjects, fT4 was a significant predictor of MetS only in non-obese subjects after adjusting for age, sex, and smoking (β = 0.49 [CI 0.29-0.83], p = 0.007) and also after further adjustment for Homeostasis Model Assessment Index for Insulin Resistance (β = 0.57 [CI 0.34-0.96], p = 0.03). Serum TSH variations over time were not associated with any of the MetS components or with odds of MetS. CONCLUSION: A decrease in serum fT4 values is associated with an increased risk for MetS, especially in non-obese adults.
引用
- Mehran L, Amouzegar A, Bakhtiyari M, et al. Variations in Serum Free Thyroxine Concentration Within the Reference Range Predicts the Incidence of Metabolic Syndrome in Non-Obese Adults: A Cohort Study. Thyroid. 2017. PMID: 28486021. doi:10.1089/thy.2016.0557
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。